TORe: A Leading Nonsurgical Revision for Gastric Bypass
Quick Answer
Watch Related Video
Introduction
Many gastric bypass patients do incredibly well for years — until something changes.
They start feeling hungrier.
Portions slowly increase.
Weight begins creeping back.
The “full” feeling they used to rely on disappears.
This is not failure.
This is not lack of discipline.
This is outlet dilation, a normal anatomical change that can happen over time.
TORe — Transoral Outlet Reduction — is one of the most effective, least invasive ways to help restore the original power of the gastric bypass without surgery, incisions, or long recovery.
This article explains exactly how it works, why it works, and who benefits most.
1. Why Weight Regain Happens After Gastric Bypass
Gastric bypass works by:
- Creating a small stomach pouch
- Creating a narrow outlet (the gastrojejunal anastomosis, or GJA)
- Slowing food passage
- Triggering strong satiety signals
- Increasing GLP-1 and PYY
- Reducing ghrelin
Over time, the outlet can stretch — just like any soft tissue in the body.
When the outlet stretches:
- Food empties too quickly
- Fullness signals weaken
- Hunger increases
- Cravings return
- Portion sizes grow
- Weight regain begins
This is not the patient’s fault.
This is normal physiology.
2. What TORe Is — and Why It Works
TORe is an endoscopic procedure performed through the mouth.
No incisions.
No scars.
No external wounds.
Using an endoscopic suturing device, the stretched outlet is tightened back to its original size.
What this accomplishes:
- Restores restriction
- Slows gastric emptying
- Reactivates satiety hormones
- Reduces hunger
- Reduces cravings
- Helps restart weight loss
It is the closest thing to “resetting” the gastric bypass.
3. How TORe Is Performed
The procedure is done under sedation or anesthesia.
Steps:
- An endoscope is passed through the mouth into the pouch.
- The enlarged outlet is measured.
- Sutures are placed around the outlet to tighten it.
- The opening is reduced to a smaller, controlled diameter.
- The patient goes home the same day.
There are no incisions and no external wounds.
4. Expected Results After TORe
Most patients experience:
- Early fullness
- Reduced hunger
- Smaller portions
- Fewer cravings
- Renewed weight loss
- Improved control
Typical outcomes:
- Meaningful additional weight loss
- Strong appetite reduction
- Long-term durability when paired with lifestyle support
Results vary, but TORe is one of the most studied nonsurgical revision options after gastric bypass.
5. Who Is a Good Candidate for TORe?
You may benefit from TORe if you:
- Had gastric bypass
- Lost weight initially
- Regained weight over time
- Feel less restriction than before
- Feel hungry sooner after meals
- Can eat larger portions than expected
- Have documented outlet dilation
- Want a nonsurgical solution
TORe is especially effective for patients who say:
- “I used to feel full quickly — now I don’t.”
- “My bypass doesn’t feel like it used to.”
- “I’m hungry all the time again.”
These are classic signs of outlet dilation.
6. How TORe Compares to Other Revision Options
Compared to surgical revision:
- Lower risk
- No incisions
- Faster recovery
- Lower complication rate
- No hospital stay
- No rerouting of intestines
Compared to medications alone:
- More durable
- Restores mechanical restriction
- Enhances hormonal response
- Works synergistically with GLP-1s
Compared to redo bypass or pouch resizing:
- Much safer
- Less invasive
- Fewer long-term risks
When the outlet has stretched, TORe is often the first-line treatment for weight regain after bypass.
7. Recovery After TORe
Most patients:
- Go home the same day
- Resume normal activities within 24–48 hours
- Follow a short liquid diet
- Transition to soft foods over 1–2 weeks
- Return to full diet gradually
Discomfort is usually mild and short-lived.
8. Why TORe Works So Well: The Physiology
TORe restores the original gastric bypass physiology:
- Slower emptying → stronger satiety
- Smaller outlet → smaller portions
- Increased GLP-1 → reduced hunger
- Improved gut-brain signaling → fewer cravings
This is not a “tightening.”
This is a metabolic reactivation.
9. The Most Important Message: You Didn’t Fail — Your Anatomy Changed
If you’re considering TORe, here’s what I want you to know:
You didn’t fail your bypass.
Your bypass didn’t fail you.
Your anatomy adapted — as it always does.
TORe exists to help you:
- Reclaim control
- Restore fullness
- Reduce hunger
- Restart weight loss
- Improve metabolic health
- Protect long-term success
This is not about blame.
This is about treating a chronic disease with the right tools.
Conclusion
TORe is one of the most effective, least invasive ways to help restore the power of gastric bypass when weight regain occurs.
It is:
- Safe
- Incisionless
- Outpatient
- Metabolically effective
- Durable
- Life-changing for the right patient
If your bypass no longer feels like it used to, TORe may be the tool that brings your biology — and your results — back on track.
Further Information
For additional context and a deeper professional perspective, you can read the companion LinkedIn article linked below.
Read on LinkedIn: A Camera Through the Mouth Is Replacing Second Surgeries for Weight Regain
Medical Topics Covered
Dr. de la Cruz‑Muñoz specializes in advanced minimally invasive and robotic surgery, metabolic disease management, and comprehensive long‑term patient care. His work integrates clinical expertise, academic leadership, and a commitment to evidence‑based medicine. He has trained surgeons across the country, contributed to national guidelines, and is widely regarded for his outcomes, innovation, and patient‑centered approach.
Patients choose Dr. de la Cruz‑Muñoz for his combination of surgical excellence, metabolic expertise, and lifelong dedication to improving patient health through compassionate, high‑quality care.
Procedures We Offer
FAQ
On average, patients lose about 8.9% of total body weight at 12 months, and roughly 7–9% is maintained through 3–5 years in the largest long-term series (Jirapinyo et al., Gastrointestinal Endoscopy, 2025; Jirapinyo et al., Gastrointestinal Endoscopy, 2020). Results improve substantially with technique and adjuncts: a purse-string suture pattern achieves about 12.8% total weight loss, and combining TORe with anti-obesity medication yields about 15.2% at one year (Jirapinyo & Thompson, Gastrointestinal Endoscopy, 2023).
The best candidates are patients who had Roux-en-Y gastric bypass and are regaining weight (or never lost enough) because the outlet between the pouch and intestine has stretched — typically to 25 mm or more — and who are committed to long-term follow-up (Jirapinyo et al., Gastrointestinal Endoscopy, 2020; Vansteenbrugge et al., Obesity Surgery, 2023). It also treats dumping syndrome from a dilated outlet. TORe is not appropriate if the outlet is already narrow, if there is an active marginal ulcer, or if there is a large hiatal hernia (Reicher et al., Obesity Surgery, 2023).
People Also Ask
Obesity is recognized as a chronic disease by major medical organizations, including the American Medical Association. It is influenced by genetics, hormones, brain signaling, environment, sleep, stress and medications — not simply willpower. Like other chronic diseases, it often requires long-term treatment, which may include nutrition, activity, behavioral support, medications and surgery. Lifestyle matters, but biology largely determines how the body responds.
The body has powerful systems that defend its weight. When you lose weight, hunger hormones rise, fullness hormones drop, the brain becomes more focused on food and metabolism slows — a process called metabolic adaptation. Genetics, sleep, stress, medications and the modern food environment add to the challenge. These are biological forces, not character flaws, which is why medical treatment is often needed.
Genetics play a major role. Studies of twins and adopted children suggest that roughly 40–70% of the variation in body weight is inherited, influencing appetite, fullness, metabolism and where fat is stored. Many genes each contribute a small effect, and a few rare single-gene forms cause severe early obesity. Genes interact with environment, sleep, stress and medications, so a family history raises risk but does not determine destiny.
GLP-1 medications mimic a natural gut hormone released after eating. They act on the brain to reduce hunger and increase fullness, slow stomach emptying so meals last longer, quiet "food noise," and improve insulin release and blood sugar. Tirzepatide also acts on a second hormone, GIP. In clinical trials, these medications produced average weight loss of about 15–20% (Wilding et al., New England Journal of Medicine, 2021; Jastreboff et al., New England Journal of Medicine, 2022).
Yes. Obesity is associated with more than 200 health conditions, including type 2 diabetes, high blood pressure, high cholesterol, heart disease, stroke, sleep apnea, fatty liver disease, reflux, osteoarthritis, infertility and PCOS, depression and at least 13 types of cancer. Losing weight — through medical treatment or bariatric surgery — improves or resolves many of these conditions.
Dieting alone usually cannot overcome the body's biological defenses against weight loss. As weight falls, hunger hormones rise, fullness hormones fall and metabolism slows — changes that can last for years. Most people regain the majority of diet-related weight loss within several years. That is not a failure of willpower, and it is why treatments that address appetite biology, such as GLP-1 medications and bariatric surgery, are more effective for many people with obesity.
Consider medical evaluation when excess weight affects your health, mobility or quality of life, or when you have related conditions such as prediabetes, diabetes, high blood pressure, sleep apnea, fatty liver or joint pain. Guidelines support medications for adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition, and surgery for a BMI of 35 or higher, or 30 or higher with metabolic disease. Early treatment can help prevent complications.
Yes. Bariatric surgery treats the biological drivers of obesity, changing hunger and fullness hormones, insulin sensitivity and the weight the body defends. It is the most effective and durable treatment for severe obesity, producing large, sustained weight loss and improving or resolving diabetes, high blood pressure, sleep apnea and fatty liver. Long-term studies show it also reduces the risk of heart disease, cancer and early death.
![Weight Regain After Gastric Bypass — 3 Causes, Every Fix [Surgeon Data]](https://cdn.prod.website-files.com/6a3a2e66e2e7d26264c335ca/6af0f0e1afd1b8985f3c60f7_video-weight-regain-after-gastric-bypass-3-causes-every-fix.webp)
